SRPT: Total dodolan perusahaan sarepta.com

sarepta.com - logo grafis emiten SRPT

Sarepta Therapeutics, Inc. (SRPT) generates revenue from exclusive RNA-based drugs protected by complex patents and orphan drug status. The company's commercial sales volume, as shown on this GURU.Markets chart, confirms revenue growth, where the value 1.96 reflects the metric's balance. Current success is based on the expansion of insurance reimbursements, which has allowed the company to optimize R&D costs and stabilize operational activities.

Sarepta (SRPT) - Pendapatan lan volume dodolan saka 04.07.2022 nganti 18.11.2026

Rincian metrik komprehensif lan analitis Sarepta Therapeutics (SRPT)

- rega saham lan prakiraan rega para ahli:
Analisis komprehensif perusahaan:Sarepta Therapeutics, Inc. (SRPT)
Barang unggulan Sarepta

This aggregate sales figure confirms the status of Sarepta Therapeutics, Inc. (SRPT) as a leader in the therapy of rare muscle pathologies. The metric captures actual cash flow, reflecting the dynamics of consumer demand for the drugs. Rising values indicate effective business scaling and an expansion of market share. Dominance in the treatment of Duchenne muscular dystrophy allows the issuer to maintain high pricing power. This ensures the stability of fundamental positions during shifts in market trends.

Pesaing wigati

Tempus AI, Inc. (TEM) - Pendapatan reged perusahaan|Dodolan perusahaan QGEN (Qiagen NV)|Pendapatan lan volume dodolan Ionis Pharmaceuticals, Inc. (IONS)|Pendapatan lan volume dodolan RGEN (Repligen Inc.)|Avidity Corp (RNA) - Total pendapatan perusahaan|CRSP - Pendapatan perusahaan|Pendapatan reged perusahaan genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Pendapatan perusahaan|Total pendapatan perusahaan Beam Therapeutics Corp (BEAM)|TWST (twistbioscience.com) - Pendapatan lan volume dodolan|Volume dodolan perusahaan TXG (10x Genomics Corp)|Pendapatan lan volume dodolan NTLA|Pendapatan lan volume dodolan Stoke Therapeutics, Inc. (STOK)|Pendapatan perusahaan BioLife BLFS|WVE - Dodolan perusahaan|Maze Therapeutics Corp - Pendapatan lan volume dodolan|Sionna Pharma - Total dodolan perusahaan|Prime Medicine (PRME) - Pendapatan perusahaan|tayshagtx.com (TSHA) - Pendapatan lan volume dodolan|Pendapatan perusahaan uniQure Corp|MGTX: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan RGNX|Pendapatan reged perusahaan Solid Corp|Pendapatan lan volume dodolan OCGN (ocugen.com)|PACB (Pacific Biosciences) - Pendapatan tahunan perusahaan|Benitec Biopharma Inc - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Pendapatan perusahaan|4D Molecular Therapeutics (FDMT) - Pendapatan lan volume dodolan|LXEO (Lexeo Therapeutics, Inc.) - Pendapatan lan volume dodolan|Total pendapatan perusahaan korrobio.com KRRO|Dodolan perusahaan EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Volume dodolan perusahaan|Pendapatan perusahaan ProQR Therapeutics N.V. PRQR|Pendapatan reged perusahaan Codexis, Inc. (CDXS)|SGMO - Pendapatan perusahaan|nautilus.bio - Total dodolan perusahaan|Metagenomi, Inc (MGX) - Pendapatan perusahaan|Volume dodolan perusahaan DTIL|Pendapatan perusahaan Generation Bio|Pendapatan lan volume dodolan Boundless Bio Inc|Pendapatan perusahaan Exicure Corp (XCUR)|Pendapatan reged perusahaan Imunon|Pendapatan lan volume dodolan PHIO (phiopharma.com)|Total volume dodolan perusahaan mustangbio.com|RNAZ - Pendapatan perusahaan|Total pendapatan perusahaan Bionano Genomics|APDN: Pendapatan lan volume dodolan|Volume dodolan perusahaan BLUE|Dodolan perusahaan IPA|OMGA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan OMIC|Pendapatan reged perusahaan Regulus Therapeutics|Pendapatan perusahaan Syros SYRS|Pendapatan dodolan perusahaan TBIO|TCON: Dodolan perusahaan|Unity Biotechnology, Inc. (UBX) - Dodolan perusahaan